Montelukast and Bilastine Combination Therapy in Allergic Rhinitis: A Narrative Review of Evidence

Surinder Jindal, Naveed N Shah, Prachi Jain, Ketaki Patil, Chaitanya Bhargave, Chintan Khandhedia, Suyog Mehta · 2026

Read Montelukast and Bilastine Combination Therapy in Allergic Rhinitis: A Narrative Review of Evidence by Surinder Jindal, Naveed N Shah, Prachi Jain, Ketaki Patil, Chaitanya Bhargave, Chintan Khandhedia, Suyog Mehta (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13524144.txt.

Description

Jindal and colleagues reviewed in 2026 the combined use of two drugs, montelukast and bilastine, for allergic rhinitis, the allergy-driven inflammation of the nose lining. The condition is triggered by antibody responses to allergens, and the released histamine and leukotrienes cause itching, sneezing, and a runny nose in children and adults alike. The team gathered studies from 2003 to 2023 that tested each drug alone and together.

Jindal found that several trials show the pair eases daytime and total nasal symptoms more than either drug alone, with the clearest gains in moderate to severe lasting disease. The two drugs complement each other: bilastine, a newer antihistamine, gives fast relief with little drowsiness, while montelukast blocks leukotrienes to cut inflammation. Data comparing the pair against other paired products on the market remain thin, so best use and long-term safety need more study.

Catalog record

CREATORSurinder Jindal, Naveed N Shah, Prachi Jain, Ketaki Patil, Chaitanya Bhargave, Chintan Khandhedia, Suyog Mehta
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13524144

Browse the full library · About the Tower of Babel